| Wasan, Ajay |
| Completed | 4 | 1014 | US | Enhanced Self-Care (ESC), Acceptance and Commitment Therapy (ACT), Evidence-Based Exercise and Manual Therapy (EBEM), Duloxetine, Cymbalta | University of North Carolina, Chapel Hill, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Chronic Low-back Pain | 07/24 | 10/24 | | |
| Recruiting | 2/3 | 330 | US | Antidepressant, AD: aripiprazole, bupropion, duloxetine, escitalopram, mirtazapine, sertraline, venlafaxine, Enhanced Fear Avoidance Rehabilitation, EFAR | Ajay Wasan, MD, Msc, National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Brigham and Women's Hospital, Mayo Clinic | Chronic Low Back Pain, Negative Affectivity | 12/25 | 04/26 | | |
NCT05025787: A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain. |
|
|
| Completed | 2 | 77 | US | CNTX-6970, Placebo | Maurizio Fava, MD | Knee Osteoarthritis | 06/24 | 06/24 | | |
NCT05476276: EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy |
|
|
| Recruiting | 2 | 122 | US | ISA specific | James P. Rathmell, MD, New York University, Icahn School of Medicine at Mount Sinai, National Institute of Neurological Disorders and Stroke (NINDS) | Painful Diabetic Neuropathy | 01/25 | 01/25 | | |
| Recruiting | 2 | 122 | US | NRD135SE.1, NRD135s.E1, a small chemical entity for treatment of neuropathic pain, Placebo | James P. Rathmell, MD, New York University, National Institute of Neurological Disorders and Stroke (NINDS), Icahn School of Medicine at Mount Sinai | Painful Diabetic Neuropathy | 01/25 | 01/25 | | |
| Completed | N/A | 26 | US | Flowly (TMC-CP01), Virtual Reality | Ajay Wasan, MD, Msc, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) | Chronic Low-back Pain | 01/24 | 01/24 | | |
| Completed | N/A | 32 | US | Occupational Therapy, OT, Occupational Therapy +Virtual Reality, OT+VR | University of Pittsburgh | Chronic Pain | 09/23 | 09/23 | | |
| Recruiting | N/A | 170 | US | There is no intervention. It is a phenotyping study only | University of Pittsburgh, National Institutes of Health (NIH), National Center for Complementary and Integrative Health (NCCIH) | Chronic Low-back Pain, Myofascial Pain | 12/25 | 12/27 | | |
| Eack, Shaun M |
NCT06562608: Anticholinergic Deprescription in Schizophrenia |
|
|
| Not yet recruiting | 4 | 105 | US | Anticholinergic Deprescription, No Anticholinergic Deprescription | Deepak K. Sarpal, M.D., National Institute of Mental Health (NIMH) | Schizophrenia, Schizoaffective Disorder | 12/28 | 06/29 | | |
| Completed | N/A | 86 | US | Cognitive Enhancement Therapy, Enriched Supportive Therapy | University of Pittsburgh, National Institute of Mental Health (NIMH) | Autistic Disorder, Autism Spectrum Disorder, Asperger Syndrome, Pervasive Developmental Disorder | 05/22 | 12/24 | | |
NCT04143126: Promoting Activity and Cognitive Enrichment in Schizophrenia (PACES) |
|
|
| Recruiting | N/A | 90 | US | Cognitive Enhancement Therapy, CET, Enriched Supportive Therapy, EST | University of Pittsburgh, National Institute of Mental Health (NIMH) | Schizophrenia | 06/25 | 06/25 | | |
| Cochran, Gerald |
| Recruiting | N/A | 80 | US | Clinical Decision Support Tool (Moderate Risk), Clinical Decision Support Tool (High Risk), Standard of Care | University of Utah, University of Cincinnati, National Institute on Drug Abuse (NIDA) | Opioid Abuse, Prescription Opioid Abuse | 07/26 | 03/27 | | |
| Recruiting | N/A | 350 | US | Patient Navigation, Standard Medication Counseling (SMC) | Jerry Cochran, National Institute on Drug Abuse (NIDA) | Opioid Misuse, Opioid-Related Disorders, Pharmacist-Patient Relations | 01/26 | 12/26 | | |
| Hruschak, Valerie |
| No trials found |
| Daniel, Rosen |
| No trials found |
